A detailed history of Pnc Financial Services Group, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 912 shares of COLL stock, worth $28,007. This represents 0.0% of its overall portfolio holdings.

Number of Shares
912
Previous 519 75.72%
Holding current value
$28,007
Previous $16,000 118.75%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$31.4 - $39.07 $12,340 - $15,354
393 Added 75.72%
912 $35,000
Q2 2024

Aug 09, 2024

BUY
$31.36 - $39.99 $125 - $159
4 Added 0.78%
519 $16,000
Q1 2024

May 10, 2024

BUY
$31.23 - $40.91 $1,780 - $2,331
57 Added 12.45%
515 $19,000
Q4 2023

Feb 09, 2024

SELL
$21.16 - $30.8 $2,602 - $3,788
-123 Reduced 21.17%
458 $14,000
Q3 2023

Nov 13, 2023

BUY
$21.23 - $24.28 $106 - $121
5 Added 0.87%
581 $12,000
Q2 2023

Aug 11, 2023

SELL
$21.06 - $24.0 $63 - $72
-3 Reduced 0.52%
576 $12,000
Q1 2023

May 15, 2023

BUY
$23.0 - $29.88 $483 - $627
21 Added 3.76%
579 $13,000
Q4 2022

Feb 10, 2023

SELL
$16.14 - $23.55 $338 - $494
-21 Reduced 3.63%
558 $12,000
Q3 2022

Nov 10, 2022

BUY
$15.46 - $20.1 $1,746 - $2,271
113 Added 24.25%
579 $9,000
Q2 2022

Aug 12, 2022

SELL
$14.22 - $20.88 $24,998 - $36,707
-1,758 Reduced 79.05%
466 $8,000
Q1 2022

May 12, 2022

BUY
$17.2 - $22.5 $26,797 - $35,055
1,558 Added 233.93%
2,224 $45,000
Q4 2021

Feb 11, 2022

BUY
$17.5 - $21.35 $5,897 - $7,194
337 Added 102.43%
666 $12,000
Q3 2021

Nov 05, 2021

SELL
$17.75 - $25.39 $16,631 - $23,790
-937 Reduced 74.01%
329 $6,000
Q2 2021

Aug 06, 2021

BUY
$21.74 - $25.28 $19,566 - $22,752
900 Added 245.9%
1,266 $29,000
Q1 2021

May 07, 2021

BUY
$19.25 - $26.1 $7,045 - $9,552
366 New
366 $8,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.05B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.